SLC5A2 and hydrops fetalis: Recent studies indicate improved HF outcomes and fewer hospital admissions in patients receiving combined treatment with lifestyle interventions and SGLT2 inhibitors, highlighting the importance of an integrative therapeutic approach [38-40].